Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Hatten Bali Tbk. (WINE)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Hatten Bali Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Hatten Bali Tbk. diperdagangkan di Rp129 (kapitalisasi pasar 357,72 M, volume 24 jam 823,4 rb). Perbedaan utamanya: Hatten Bali Tbk. jauh lebih besar — sekitar 3,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WINE | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 357,72 M |
Volume | — | 823,4 rb |
Lot | — | 8,23 rb |
Perputaran | — | 106,82 jt |
Harga Rata-rata | — | 129,73 |
Nilai Transaksi | — | 106,82 jt |
Harga Ekuilibrium Indikatif | — | 129 |
Volume Ekuilibrium Indikatif | — | 2 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Hatten Bali Tbk.
PT Hatten bali, Tbk. (the Company) was established in Bali based on the Notarial Deed No. 90, dated April 15, 2000, drawn up before, I Putu Chandra, S.H Notary at Denpasar. The Company started its commercial operations in 2003.
Selengkapnya di halaman WINE →
